The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Update from EHA 2020: Targeted therapy in CLL

Sep 9, 2020

During the 25th European Hematology Association (EHA) Annual Congress, the Lymphoma Hub was pleased to speak to Steering Committee Member Astrid Pavlovsky, Fundaleu CHP, Buenos Aires, AR, about targeted therapy in CLL.

Update from EHA 2020: Targeted therapy in CLL

This interview outlines the latest in frontline CLL from EHA 2020, including results from the CLL-14 trial, CAPTIVATE MRD cohort, and CLL2-GIVe study.